The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...

Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well ...

John Arena, interim president of global pharma services at Cencora, discusses how new technologies are shortening timelines.

Unconfirmed reports suggest that a popular flu vaccine educational campaign has come to an end.

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development ...

John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at ...

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

Under terms of the deal, Stoke will spearhead global development of zorevunersen, while Biogen will receive exclusive rights ...

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...